Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APG-157 in Oral Dysplasia
NCT05865028Phase 2Recruiting
- Start
- May 2023
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of APG-157 in oral dysplasia (OED), oral carcinoma in situ (OCIS). Started May 2023; status: recruiting.
02
Drugs
APG-157
03
Conditions
oral dysplasia (OED)oral carcinoma in situ (OCIS)
Beyond the preview
Go deeper on NCT05865028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05865028.